Olmetor 20 Tablet contains Olmesartan Medoxomil 20 mg, an angiotensin II receptor blocker (ARB) used primarily for the management of hypertension. By selectively inhibiting the binding of angiotensin II to the AT1 receptor, Olmesartan Medoxomil promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension, such as stroke, myocardial infarction, and renal impairment. Olmetor 20 is indicated for adult patients with essential hypertension and may be used as monotherapy or in combination with other antihypertensive agents. The tablet is typically administered once daily, with or without food, and dosage adjustments should be individualized based on patient response and tolerability. Common adverse effects include dizziness, headache, and fatigue, while serious adverse reactions are rare but may involve hypotension or renal dysfunction, particularly in patients with compromised renal function or volume depletion. Olmetor 20 is contraindicated in patients with hypersensitivity to Olmesartan Medoxomil or any component of the formulation, and caution is advised during pregnancy due to potential fetal harm. Regular monitoring of blood pressure, renal function, and electrolytes is recommended to ensure therapeutic efficacy and safety during treatment.